burosumab-twza (crysvita) Report issue

Biologics mAb Orphan Drug FDA Approved FDA Fast Track FDA Priority Review FDA
Back

Drug Pricing Summary

VA Big4

$2556.3900 - $7692.6800

VA FSS

$3394.6200 - $10183.8700

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
burosumab 10 mg / 1 mL (1 mL INJECTION) $2556.3900 VA Big4
  • CRYSVITA (1)
  • Ultragenyx Pharmaceuticals, Inc.
    burosumab 10 mg / 1 mL (1 mL INJECTION) $3394.6200 VA FSS
  • CRYSVITA (1)
  • Ultragenyx Pharmaceuticals, Inc.
    burosumab 20 mg / 1 mL (1 mL INJECTION) $5114.7600 VA Big4
  • CRYSVITA (1)
  • Ultragenyx Pharmaceuticals, Inc.
    burosumab 20 mg / 1 mL (1 mL INJECTION) $6789.2500 VA FSS
  • CRYSVITA (1)
  • Ultragenyx Pharmaceuticals, Inc.
    burosumab 30 mg / 1 mL (1 mL INJECTION) $7692.6800 VA Big4
  • CRYSVITA (1)
  • Ultragenyx Pharmaceuticals, Inc.
    burosumab 30 mg / 1 mL (1 mL INJECTION) $10183.8700 VA FSS
  • CRYSVITA (1)
  • Ultragenyx Pharmaceuticals, Inc.

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue